Guava leaf, green tea leaf, and rose petal extracts were purchased from Daejong Biotech Co., Ltd. (Seoul, Korea). We then prepared BEN815 by mixing these extracts in a 65:30:5 ratio, respectively. The active compounds were quercetin, EGCG, ellagic acid, gallic acid, kaempferol, and myricetin, the content and efficacy of which were analyzed in a previous study [15 (link)]. The mixture was dissolved in 0.9% saline and stored at -20°C. Nirmatrelvir was obtained from MedChemExpress (Monmouth Junction, NJ, USA); a stock solution was prepared by dissolving Nirmatrelvir in 0.9% saline containing 1% dimethyl sulfoxide and 20% sulfobutylether-β-cyclodextrin (MedChemExpress), which was stored at -20°C.
Free full text: Click here